B
Bull
Bull · 25%WBA
$10.84
Scenario price
$11.980
+0.060 (+0.50%)At close
Loading chart…
- High
- 12.110
- Open
- 11.915
- VWAP
- 12.00
- Vol
- 452.08M
- Mkt Cap
- 10.52B
- Low
- 11.900
- Amount
- 5.42B
- EV/EBITDA, TTM
- 11.73
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Analyst Ratings (24)
-4.42% downside
Buy
15 Buy
9 Hold
0 Sell
Current: 11.98
Low
11.45
Average
11.45
High
11.45
Deutsche Bank
Strong Sell
$9
2025-02-28
Deutsche Bank
2025-02-28
Price Target
$9
Strong Sell
Truist Securities
Hold
$12
2025-01-31
Truist Securities
2025-01-31
Price Target
$12
Hold
Truist Securities
Hold
$13
2025-01-16
Truist Securities
2025-01-16
Price Target
$13
Hold
RBC Capital
Hold
$12
2025-01-15
RBC Capital
2025-01-15
Price Target
$12
Hold
B of A Securities
Sell
$8.5
2025-01-13
B of A Securities
2025-01-13
Price Target
$8.5
Sell
Valuation Metrics
The current forward P/E ratio for Walgreens Boots Alliance Inc (WBA) is 7.78, compared to its 5-year average forward P/E of 8.00.
Alphio AI Price Scenarios for WBA
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
2.003-22CNBCRising Menstrual Product Prices Squeeze Consumers
4.503-17CNBCOil Prices Rise, Boosting Stock Market Performance
8.002-20Yahoo FinanceWalgreens Lays Off 469 Employees Amid Business Reorganization
4.502-06CNBCDow Jones Index Surpasses 50,000 for the First Time
8.502-02CNBCAnalysis of Store Openings and Closures in U.S. Retail Sector
WBA FAQ — answered by Alphio AI
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey. It operates in the Consumer Non-Cyclicals sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).
24 analysts cover WBA: 15 rate it Buy, 9 Hold and 0 Sell. The average price target is 11.45.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.